Toronto Dominion Bank purchased a new position in Healthpeak Properties, Inc. (NYSE:DOC – Free Report) in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 349,933 shares of the real estate investment trust’s stock, valued at approximately $8,003,000. Toronto Dominion Bank owned 0.05% of Healthpeak Properties at the end of the most recent reporting period.
Other hedge funds also recently made changes to their positions in the company. HM Payson & Co. bought a new position in Healthpeak Properties in the 3rd quarter worth about $25,000. S.A. Mason LLC bought a new position in shares of Healthpeak Properties in the third quarter valued at approximately $26,000. Rise Advisors LLC purchased a new position in Healthpeak Properties during the third quarter valued at approximately $29,000. Fortitude Family Office LLC bought a new stake in Healthpeak Properties during the 3rd quarter worth approximately $32,000. Finally, Barrett & Company Inc. purchased a new stake in Healthpeak Properties in the 3rd quarter worth approximately $33,000. 93.57% of the stock is currently owned by hedge funds and other institutional investors.
Healthpeak Properties Stock Performance
NYSE DOC opened at $20.76 on Friday. The company has a 50-day simple moving average of $21.94 and a two-hundred day simple moving average of $21.36. Healthpeak Properties, Inc. has a 12-month low of $16.01 and a 12-month high of $23.26. The firm has a market cap of $14.52 billion, a price-to-earnings ratio of 44.17, a PEG ratio of 2.37 and a beta of 1.13. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93.
Healthpeak Properties Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Monday, November 4th were issued a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 5.78%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio is 255.32%.
Analyst Ratings Changes
A number of research analysts have recently commented on the stock. Citigroup boosted their price target on shares of Healthpeak Properties from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Deutsche Bank Aktiengesellschaft upgraded Healthpeak Properties from a “hold” rating to a “buy” rating and upped their target price for the stock from $20.00 to $28.00 in a research note on Monday, October 21st. Wells Fargo & Company dropped their price target on Healthpeak Properties from $23.00 to $22.00 and set an “equal weight” rating for the company in a research report on Tuesday, December 10th. Robert W. Baird upped their price objective on shares of Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, Evercore ISI lifted their target price on shares of Healthpeak Properties from $25.00 to $26.00 and gave the company an “outperform” rating in a research report on Monday, September 16th. One investment analyst has rated the stock with a sell rating, five have given a hold rating, ten have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $22.93.
Read Our Latest Stock Analysis on Healthpeak Properties
Healthpeak Properties Company Profile
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
Featured Stories
- Five stocks we like better than Healthpeak Properties
- There Are Different Types of Stock To Invest In
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- How Investors Can Find the Best Cheap Dividend Stocks
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Want to see what other hedge funds are holding DOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Healthpeak Properties, Inc. (NYSE:DOC – Free Report).
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.